LLY · Categories · Downgrades
LLY - Analyst downgrades
Eli Lilly and Company (LLY) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for LLY
- Eli Lilly downgraded by HSBC Securities with a new price targetHSBC Securities downgraded Eli Lilly from Hold to Reduce and set a new price target of $850.00
- Eli Lilly downgraded by Berenberg with a new price targetBerenberg downgraded Eli Lilly from Buy to Hold and set a new price target of $830.00
- Eli Lilly downgraded by Daiwa Securities with a new price targetDaiwa Securities downgraded Eli Lilly from Outperform to Neutral and set a new price target of $700.00
- Eli Lilly downgraded by Leerink Partners with a new price targetLeerink Partners downgraded Eli Lilly from Outperform to Market Perform and set a new price target of $715.00
- Eli Lilly downgraded by Erste GroupErste Group downgraded Eli Lilly from Buy to Hold
- Eli Lilly downgraded by HSBC Securities with a new price targetHSBC Securities downgraded Eli Lilly from Buy to Reduce and set a new price target of $700.00 from $1,150.00 previously
- Eli Lilly downgraded by DZ Bank with a new price targetDZ Bank downgraded Eli Lilly from Buy to Hold and set a new price target of $820.00
- Eli Lilly downgraded by Daiwa Securities with a new price targetDaiwa Securities downgraded Eli Lilly from Buy to Outperform and set a new price target of $610.00 from $660.00 previously
- Eli Lilly downgraded by Societe GeneraleSociete Generale downgraded Eli Lilly from Hold to Sell